These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2583114)

  • 1. Internalization and recycling of CD4 transfected into HeLa and NIH3T3 cells.
    Pelchen-Matthews A; Armes JE; Marsh M
    EMBO J; 1989 Dec; 8(12):3641-9. PubMed ID: 2583114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocytosis of glycophospholipid-anchored and transmembrane forms of CD4 by different endocytic pathways.
    Keller GA; Siegel MW; Caras IW
    EMBO J; 1992 Mar; 11(3):863-74. PubMed ID: 1532143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M; Gold AM; Ferrone S
    Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragments.
    Kinne RW; Schemer K; Behr T; Sharkey RM; Palombokinne E; Emmrich F; Goldenberg DM; Wolf F; Becker W
    Nucl Med Commun; 1999 Jan; 20(1):67-75. PubMed ID: 9949415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens.
    Fjeld JG; Michaelsen TE; Nustad K
    Eur J Nucl Med; 1992; 19(6):402-8. PubMed ID: 1618231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits.
    Pelchen-Matthews A; Boulet I; Littman DR; Fagard R; Marsh M
    J Cell Biol; 1992 Apr; 117(2):279-90. PubMed ID: 1373141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
    Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
    J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody.
    Chen SY; Khouri Y; Bagley J; Marasco WA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5932-6. PubMed ID: 8016092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
    Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL
    Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells.
    Pelchen-Matthews A; Armes JE; Griffiths G; Marsh M
    J Exp Med; 1991 Mar; 173(3):575-87. PubMed ID: 1900077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4.
    Bachelder RE; Bilancieri J; Lin W; Letvin NL
    J Virol; 1995 Sep; 69(9):5734-42. PubMed ID: 7637018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for C3b on the neutrophil surface associate with the cytoskeleton-containing cell residue subsequent to cell lysis with non-ionic detergent. Cytoskeletal-CR1 interactions.
    Katz JD; Rimmerman CM; Berrettoni BA; Hafeman DG
    J Immunol Methods; 1987 May; 99(1):83-93. PubMed ID: 2952734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cluster of differentiation antigen 4 (CD4) endocytosis and adaptor complex binding require activation of the CD4 endocytosis signal by serine phosphorylation.
    Pitcher C; Höning S; Fingerhut A; Bowers K; Marsh M
    Mol Biol Cell; 1999 Mar; 10(3):677-91. PubMed ID: 10069811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of an activated T-cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD26.
    Duke-Cohan JS; Morimoto C; Schlossman SF
    Blood; 1993 Oct; 82(7):2224-34. PubMed ID: 8104537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands.
    Mongini PK; Blessinger CA; Chiorazzi N; Rajaram N; Rudich SM
    Int Immunol; 1995 Feb; 7(2):317-30. PubMed ID: 7734425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
    Kozak SL; Platt EJ; Madani N; Ferro FE; Peden K; Kabat D
    J Virol; 1997 Feb; 71(2):873-82. PubMed ID: 8995603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.
    Lee S; Peden K; Dimitrov DS; Broder CC; Manischewitz J; Denisova G; Gershoni JM; Golding H
    J Virol; 1997 Aug; 71(8):6037-43. PubMed ID: 9223495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.